Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rang in Aktien #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aktienkurs
$36.75
Zuletzt synchronisiert: 2026-08-27
Marktkapitalisierung
$1.63B
Veränderung (1 Tag)
-0.78%
Veränderung (1 Jahr)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Kategorie

Kursverlauf für Avalyn Pharma Inc. Common Stock (AVLN)
Höchster Schlusskurs: $36.94 am 2026-08-01

Niedrigster Schlusskurs: $29.49 am 2026-04-01
Kursverlauf der Aktie von Avalyn Pharma Inc. Common Stock von 2026 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
Nicht genügend Daten für die angegebenen Daten.
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$763.17 7.45%
CH